Faculty

Institution

Unit

Venue

Shengqing Gu

Instructor Assistant Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Hematopoietic Biology And Malignancy

Shengqing Gu is currently serving as a Hematopoietic Biology And Malignancy Instructor Assistant Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Shengqing Gu

The University of Texas MD Anderson Cancer Center

Instructor Assistant Professor

You can click a keyword to filter the displayed items

genetics cell biology oncology cancer cells hematology leukemia cancer genetics cancer biology pharmacology medicine molecular cell biology oncogenes gynecologic oncology cancer immunosurveillance cell and molecular biology regenerative medicine haematopoiesis cell death hematological malignancies cancer screening cancer treatment computational modeling gene expression human biology pathogenesis stem cell research genome biology mammalian biology redox biology structural molecular biology experimental medicine clinical investigation cancer discovery bone marrow transplantation cell transplantation molecular basis blood flow blood cells graft survival pathogen transmission cellular biology host genetics genetic disorders host specificity myeloid neoplasia myelopoiesis oncogenic agent high-throughput screening cancer genomics omics datasets genetic basis endocrine-related cancers stem cell transplantation signaling pathways medical genetics immunologic mechanisms essential role progenitor cells hematopoietic stem braf heterodimerization common pathogenic mechanism adult hematopoiesis hematopoietic stem cells disease alleles integrative genetic analysis lymphoid transformation distinct gab2 lung cancer models cml initiation syngeneic organoid platform arid1a-mutant ovarian cancer

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 688: Pan-Cancer Mapping of Genetic Immune Escape Evolutionary Trajectories.. Cancer Research (2026)

geneticscancer immunotherapycancer geneticsimmunologycancer cells

Abstract B022: Genetic Evolution of Immune Escape Across Cancers. Cancer Research (2025)

geneticsimmune responsescancer researchimmunologycancer immunosurveillancecancer cells

Abstract Pr014: Arid4b Induces Immune Escape in High-Grade Serous Ovarian Cancer by Upregulating B3Gnt5-Mediated Glycosphingolipid Synthesis. Cancer Research (2025)

cancer biologyovarian cancerimmunologycell biologygynecologic oncologytherapeutic targets

Data From Selective Alanine Transporter Utilization is a Therapeutic Vulnerability in Arid1A-Mutant Ovarian Cancer. (2025)

cancer biologycancer cellstherapeutic vulnerabilityarid1a-mutant ovarian canceroncologyovarian cancercell biologyendocrine-related cancersgynecologic oncologygynecology

Evolutionary Trajectories of Immune Escape Across Cancers. bioRxiv (Cold Spring Harbor Laboratory) (2025)

cancer cellsimmunity (medicine)cancer immunosurveillanceimmunology

Evolution of Chronic Lymphocytic Leukemia After Allogeneic Stem Cell Transplant. bioRxiv (Cold Spring Harbor Laboratory) (2025)

pathologychronic lymphocytic leukemiaclinical transplantationstem cell transplantationhematological malignanciescell transplantationleukemiaimmunologybone marrow transplantationcell biologyhematologystem cells

Lrp-1 Regulates T Cell Proliferation and Activation Through Global Lipid Network and Loss of Lrp-1 Eliminates Gvhd in Vivo. Blood (2025)

immune responsessignal transductionimmunologic mechanismscell signalingimmunologyimmunotherapycell biologycell deathautoimmunity

Abstract 1613: Evolution of Mutations in the Antigen Presentation Machinery Across Cancers. Cancer Research (2024)

geneticscancer researchcancer discoverymolecular biologycancer geneticscarcinogenesis

Targeted Degradation of Oncogenic Krasg12V Triggers Antitumor Immunity in Lung Cancer Models. Journal of Clinical Investigation (2024)

Dezhi LiKe GengYuan HaoJiajia GuSaurav KumarAnnabel T. OlsonChristina C. KuismiHye Mi KimYuanwang PanFiona ShermanAsia M. WilliamsYiting LiFei LiTing ChenCassandra ThakurdinMichela RanieriMary MeynardieDaniel S. LevinJanaye StephensAlison ChafitzJoy ChenMia S. Donald-PaladinoJaylen M. PowellZe-Yan ZhangWei ChenMagdalena PloszajHan HanShengqing GuTinghu ZhangBaoli HuBenjamin A. NacevMedard Ernest KaizaAlice H. BergerXuerui WangJing LiXuejiao SunYang LiuXiaoyang ZhangTullia C. BrunoNathanael S. GrayBehnam NabetKwok-Kin WongHua Zhang

cancer immunotherapyimmunity (medicine)cancer cellsoncogenic agentoncogenesoncologyradiation oncologysystems biologyimmunologycancer immunosurveillancelung cancer modelsimmune responsesclinical investigationlung cancer

Data From Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer. (2023)

Shuang ZhangSonia IyerHao RanIgor DolgalevShengqing GuWei WeiConnor J.R. FosterCynthia A. LoomisNarciso OlveraFanny DaoDouglas A. LevineRobert A. WeinbergBenjamin G. Neel

geneticscancer biologyomics datasetsfunctional genomicsgenetic basissyngeneic organoid platformgene therapyoncologycancer genomicsovarian cancermolecular biologybiomolecular engineeringgynecologic oncology

1
2
3
10 / page

Shengqing Gu

Instructor Assistant Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Hematopoietic Biology And Malignancy

Shengqing Gu is currently serving as a Hematopoietic Biology And Malignancy Instructor Assistant Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Shengqing Gu

The University of Texas MD Anderson Cancer Center

Instructor Assistant Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 688: Pan-Cancer Mapping of Genetic Immune Escape Evolutionary Trajectories.. Cancer Research (2026)

geneticscancer immunotherapycancer geneticsimmunologycancer cells

Abstract B022: Genetic Evolution of Immune Escape Across Cancers. Cancer Research (2025)

geneticsimmune responsescancer researchimmunologycancer immunosurveillancecancer cells

Abstract Pr014: Arid4b Induces Immune Escape in High-Grade Serous Ovarian Cancer by Upregulating B3Gnt5-Mediated Glycosphingolipid Synthesis. Cancer Research (2025)

cancer biologyovarian cancerimmunologycell biologygynecologic oncologytherapeutic targets

Data From Selective Alanine Transporter Utilization is a Therapeutic Vulnerability in Arid1A-Mutant Ovarian Cancer. (2025)

cancer biologycancer cellstherapeutic vulnerabilityarid1a-mutant ovarian canceroncologyovarian cancercell biologyendocrine-related cancersgynecologic oncologygynecology

Evolutionary Trajectories of Immune Escape Across Cancers. bioRxiv (Cold Spring Harbor Laboratory) (2025)

cancer cellsimmunity (medicine)cancer immunosurveillanceimmunology

Evolution of Chronic Lymphocytic Leukemia After Allogeneic Stem Cell Transplant. bioRxiv (Cold Spring Harbor Laboratory) (2025)

Lrp-1 Regulates T Cell Proliferation and Activation Through Global Lipid Network and Loss of Lrp-1 Eliminates Gvhd in Vivo. Blood (2025)

immune responsessignal transductionimmunologic mechanismscell signalingimmunologyimmunotherapycell biologycell deathautoimmunity

Abstract 1613: Evolution of Mutations in the Antigen Presentation Machinery Across Cancers. Cancer Research (2024)

geneticscancer researchcancer discoverymolecular biologycancer geneticscarcinogenesis

Targeted Degradation of Oncogenic Krasg12V Triggers Antitumor Immunity in Lung Cancer Models. Journal of Clinical Investigation (2024)

Data From Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer. (2023)

Shuang ZhangSonia IyerHao RanIgor DolgalevShengqing GuWei WeiConnor J.R. FosterCynthia A. LoomisNarciso OlveraFanny DaoDouglas A. LevineRobert A. WeinbergBenjamin G. Neel

1
2
3
10 / page